Expansion Opportunity Recent facility expansion to Princeton signals capacity growth and potential for increased bioanalytical work, enabling us to position Accurant Biotech as a preferred partner for larger clinical programs requiring more robust CRO support.

Global Collaboration Presence of laboratories in the United States and China supports multi-site and multi-country trials, offering a compelling selling point to biotech and pharma firms seeking integrated global bioanalytical services and regulatory support.

Biologics Focus Specialization in bioanalytical support for large molecules and biologics aligns with high-growth segments such as monoclonal antibodies, ADCs, and recombinant proteins, presenting opportunities to upsell method development, validation, and regulatory services.

GxP & Regulatory GxP-compliant operations coupled with regulatory support capabilities position Accurant as a one-stop CRO for CMC testing and regulatory filings, appealing to sponsors looking to streamline quality and submission readiness.

Mid-Mized Scale Smaller to mid-sized biotechs and academic collaborations offer a target market with faster onboarding and potential for long-term repeat work in reagent sourcing, central lab services, and multi-site analysis as programs mature.